Rallybio Corp. (RLYB)
16.84
+0.05
(+0.30%)
USD |
NASDAQ |
Sep 01, 16:00
16.84
0.00 (0.00%)
After-Hours: 17:02
Rallybio Cash from Operations (TTM) : 26.71M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.71M |
| March 31, 2026 | -27.59M |
| December 31, 2025 | -29.81M |
| September 30, 2025 | -35.00M |
| June 30, 2025 | -41.99M |
| March 31, 2025 | -44.03M |
| December 31, 2024 | -49.28M |
| September 30, 2024 | -51.06M |
| June 30, 2024 | -53.99M |
| March 31, 2024 | -56.96M |
| December 31, 2023 | -60.26M |
| September 30, 2023 | -63.88M |
| Date | Value |
|---|---|
| June 30, 2023 | -62.15M |
| March 31, 2023 | -62.32M |
| December 31, 2022 | -57.28M |
| September 30, 2022 | -51.91M |
| June 30, 2022 | -48.04M |
| March 31, 2022 | -47.34M |
| December 31, 2021 | -45.53M |
| September 30, 2021 | -42.91M |
| June 30, 2021 | -37.66M |
| March 31, 2021 | -28.43M |
| December 31, 2020 | -22.04M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Q32 Bio, Inc. | -19.83M |
| Beam Therapeutics, Inc. | -359.38M |
| C4 Therapeutics, Inc. | -84.87M |
| Cullinan Therapeutics, Inc. | -159.25M |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |